Literature DB >> 17822667

Molecular dissection of the interaction between the SH3 domain and the SH2-Kinase Linker region in PTK6.

Han Ie Kim1, Jinwon Jung, Eun-Saem Lee, Yong-Chul Kim, Weontae Lee, Seung-Taek Lee.   

Abstract

PTK6 (also known as Brk) is an intracellular tyrosine kinase that contains SH3, SH2, and tyrosine kinase catalytic (Kinase) domains. The SH3 domain of PTK6 interacts with the N-terminal half of the linker (Linker) region between the SH2 and Kinase domains. Site-directed mutagenesis and surface plasmon resonance studies showed that a tryptophan residue (Trp44) in the SH3 domain and proline residues in the Linker region, in the order of Pro177, Pro175, and Pro179, contribute to the interaction. The three-dimensional modeled structure of the SH3-Linker complex was in agreement with the biochemical data. Disruption of the intramolecular interaction between the SH3 domain and the Linker region by mutation of Trp44, Pro175, Pro177, and Pro179 markedly increased the catalytic activity of PTK6 in HEK 293 cells. These results demonstrate that Trp44 in the SH3 domain and Pro177, Pro175, and Pro179 in the N-terminal half of the Linker region play important roles in the SH3-Linker interaction to maintain the protein in an inactive conformation along with the phosphorylated Tyr447-SH2 interaction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17822667     DOI: 10.1016/j.bbrc.2007.08.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Cancer-Associated Mutations in Breast Tumor Kinase/PTK6 Differentially Affect Enzyme Activity and Substrate Recognition.

Authors:  Tiffany Tsui; W Todd Miller
Journal:  Biochemistry       Date:  2015-05-13       Impact factor: 3.162

2.  Protein tyrosine kinase 6 mediates TNFα-induced endothelial barrier dysfunction.

Authors:  R J Haines; R S Beard; M H Wu
Journal:  Biochem Biophys Res Commun       Date:  2014-11-22       Impact factor: 3.575

3.  PTK6 promotes hepatocellular carcinoma cell proliferation and invasion.

Authors:  Xiaohong Chen; Bo Song; Yuanlong Lin; Lijun Cao; Shiyan Feng; Lin Zhang; Fuxiang Wang
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 4.  Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.

Authors:  Patrick M Brauer; Angela L Tyner
Journal:  Biochim Biophys Acta       Date:  2010-02-26

5.  The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-catenin.

Authors:  Patrick M Brauer; Yu Zheng; Mark D Evans; Carmen Dominguez-Brauer; Donna M Peehl; Angela L Tyner
Journal:  PLoS One       Date:  2011-03-30       Impact factor: 3.240

Review 6.  Putting the BRK on breast cancer: From molecular target to therapeutics.

Authors:  Hui Li Ang; Yi Yuan; Xianning Lai; Tuan Zea Tan; Lingzhi Wang; Benjamin BoJun Huang; Vijay Pandey; Ruby Yun-Ju Huang; Peter E Lobie; Boon Cher Goh; Gautam Sethi; Celestial T Yap; Ching Wan Chan; Soo Chin Lee; Alan Prem Kumar
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

7.  Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo.

Authors:  S Miah; A Martin; K E Lukong
Journal:  Oncogenesis       Date:  2012-05-07       Impact factor: 7.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.